Search Results - "Chamuleau, SAJ"

A novel receptor-interacting protein-1 (RIP1) inhibitor (547) protects human cardiac cells from ischemia/reperfusion-triggered necroptotic cell death by Peters, MC, Neef, K, Markovska, A, Oerlemans, MIF, Chamuleau, SAJ, Sluijter, JPG

Get full text

The impact of valvular heart disease in patients referred for suspected coronary artery disease by Molenaar, MA, Coerkamp, CF, Man, JP, Bouma, BJ, Isgum, I, Verouden, NJ, Selder, JL, Chamuleau, SAJ, Schuuring, MJ

Get full text

P111Retention of mesenchymal stem cells in the heart is lower after retrograde coronary venous infusion compared to intracoronary infusion in a porcine model of chronic myocardial infarction by Gathier, W A, Van Der Naald, M, Van Klarenbosch, B R, Tuinenburg, A E, Bemelmans, JLM, Sluijter, JPG, Van Slochteren, F J, Doevendans, P A, Chamuleau, SAJ

Get full text

202Slow release of cardiac progenitor cell-derived extracellular vesicles from a pH-switchable hydrogel by Mol, E, Lei, Z, Bakker, M H, Vader, P, Schiffelers, R M, Dankers, PYW, Chamuleau, SAJ, Doevendans, P A, Goumans, M J, Sluijter, J P

Get full text

P324Optimal MRI-based left ventricular lead placement for cardiac resynchronization therapy in patients with an ischemic cardiomyopathy: a retrospective analysis by Gathier, W A, Van Ginkel, D J, Van Everdingen, W M, Meine, M, Van Slochteren, F J, Doevendans, P A, Chamuleau, SAJ

Get full text

Real-time correction of respiratory-induced cardiac motion during electroanatomical mapping procedures by van Es, R., van Slochteren, F. J., Jansen of Lorkeers, S. J., Blankena, R., Doevendans, P. A., Chamuleau, S. A. J.

“…Treatment planning during catheter interventions in the heart is often based on electromechanical tissue characteristics obtained by endocardial surface…”
Get full text

Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions by MEUWISSEN, Martijn, CHAMULEAU, Steven A. J, SIEBES, Maria, SCHOTBORGH, Carl E, KOCH, Karel T, DE WINTER, Robbert J, BAX, Matthijs, DE JONG, Angelina, SPAAN, Jos A. E, PIEK, Jan J

“…Fractional flow reserve (FFR) and coronary blood flow velocity reserve (CFR) represent physiological quantities used to evaluate coronary lesion severity and…”
Get full text

Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease by Chamuleau, Steven A J, Siebes, Maria, Meuwissen, Martijn, Koch, Karel T, Spaan, Jos A E, Piek, Jan J

“…Homogeneity of microvascular resistance in different perfusion areas of the same heart is generally assumed. We investigated the effect of the severity of an…”
Get more information

Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction by van der Spoel, T. I. G., Gathier, W. A., Koudstaal, S., van Slochteren, F., of Lorkeers, S. Jansen, Sluijter, J. P. G., Hoefer, I. E., Steendijk, P., Cramer, M. J. M., Doevendans, P. A., van Belle, E., Chamuleau, S. A. J.

“…Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a…”
Get full text

Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity by MEUWISSEN, Martijn, SIEBES, Maria, CHAMULEAU, Steven A. J, VAN ECK-SMIT, Berthe L. F, KOCH, Karel T, DE WINTER, Robbert J, TIJSSEN, Jan G. P, SPAAN, Jos A. E, PIEK, Jan J

“…Both coronary blood flow velocity reserve (CFVR) and myocardial fractional flow reserve (FFR) are used to evaluate the hemodynamic severity of coronary…”
Get full text

Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction by Meuwissen, M, van der Wal, A C, Niessen, H W M, Koch, K T, de Winter, R J, van der Loos, C M, Rittersma, S Z H, Chamuleau, S A J, Tijssen, J G P, Becker, A E, Piek, J J

“…Background: C reactive protein (CRP), an important serum marker of atherosclerotic vascular disease, has recently been reported to be active inside human…”
Get full text

Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis by Chamuleau, Steven A.J, Meuwissen, Martijn, Koch, Karel T, van Eck-Smit, Berthe L.F, Tio, Rene A, Tijssen, Jan G.P, Piek, Jan J

“…Intracoronary-derived, pressure-based fractional flow reserve (FFR) is important for clinical decision-making in patients with 1-vessel coronary artery disease…”
Get full text

Influence of hemodynamic conditions on fractional flow reserve: parametric analysis of underlying model by Siebes, Maria, Chamuleau, Steven A J, Meuwissen, Martijn, Piek, Jan J, Spaan, Jos A E

“…Pressure-based fractional flow reserve (FFR) is used clinically to evaluate the functional severity of a coronary stenosis, by predicting relative maximal…”
Get more information

Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease by Chamuleau, Steven A.J., Tio, Rene A., de Cock, Carel C., de Muinck, Ebo D., Pijls, Nico H.J., van Eck-Smit, Berthe L.F., Koch, Karel T., Meuwissen, Martijn, Dijkgraaf, Marcel G.W., de Jong, Angelina, Verberne, Hein J., van Liebergen, Rob A.M., Laarman, Gert Jan, Tijssen, Jan G.P., Piek, Jan J.

“…This study aimed to investigate the roles of intracoronary derived coronary flow velocity reserve (CFVR) and myocardial perfusion scintigraphy (single photon…”
Get full text

Stem cell therapy for end-stage heart failure: indispensable role for the cell? by Vrijsen, K R, Chamuleau, S A J, Noort, W A, Doevendans, P A, Sluijter, J P G

“…For heart failure patients, the urgent need for heart transplantation exceeds the availability of donor hearts. Therefore, cell transplantation has emerged as…”
Get full text

Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis by van Hout, G.P.J., Jansen of Lorkeers, S.J., Wever, K.E., Sena, E.S., van Solinge, W.W., Doevendans, P.A., Pasterkamp, G., Chamuleau, S.A.J., Hoefer, I.E.

“…ABSTRACT Targeting the inflammatory response after myocardial infarction (MI) could potentially prevent infarct expansion, resulting in a preservation of…”
Get full text

The pathophysiological basis of pharmacological interventions in CAVD by Riem Vis, P. W., van Rijswijk, J-W., Chamuleau, S. A. J., Vink, A., van Herwerden, L. A., Kluin, J.

“…Calcific aortic valve disease (CAVD) results in aortic valve stenosis and is one of the most common cardiac diseases in both Western and developing countries…”
Get full text

Fractional flow reserve: can it predict adverse events accurately after coronary stenting? by Chamuleau, Steven AJ

Get full text

Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation by Meuwissen, Martijn, van der Wal, Allard C, Koch, Karel T, van der Loos, Chris M, Chamuleau, Steven A J, Teeling, Peter, de Winter, Robbert J, Tijssen, Jan G P, Becker, Anton E, Piek, Jan J

“…Patients with unstable coronary syndromes often have complex morphology of coronary stenoses at angiography. We evaluated the association between qualitative…”
Get more information

Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina by Piek, Jan J, Van Der Wal, Allard C, Meuwissen, Martijn, Koch, Karel T, Chamuleau, Steven A.J, Teeling, Peter, Van Der Loos, Chris M, Becker, Anton E

“…OBJECTIVES To evaluate immunohistochemically various parameters of inflammation in coronary atherectomy specimens obtained from restenotic culprit lesions of…”
Get full text